PLX4720
PLX-4720 is a selective ATP-competitive inhibitor of the oncogenic B-Raf V600E mutant, exhibiting an IC50 of 13 nM. It is widely used in cancer research to study MAPK pathway signaling and has demonstrated efficacy in both cellular assays and in vivo tumor models.
Product Specifications
CAS Number
918505-84-7
Product Name Alternative
PLX4720, PLX-4720, PLX 4720, Inhibitor, inhibit, B-Raf, B-Raf (V600E), C-Raf-1 (Y340D/Y341D), Raf, Raf kinases
Field of Research
Signal Transduction
Purity
>98%
Bioactivity
Mutant B-Raf inhibitor
Form
Powder
Solubility
Soluble in DMSO (55 mg/ml with warming)
Smiles
CCCS (=O) (=O) Nc1ccc (F) c (C (=O) c2c[nH]c3ncc (Cl) cc23) c1F
Molecular Formula
C17H14ClF2N3O3S
Molecular Weight
413.8
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N-[3-[ (5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl) carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP02065SU-N 100 µL
Calcitonin (CALCA) rabbit polyclonal antibody, Serum
Sign In for Pricing
View Details